MD Anderson scientists have put the DNA of the extinct Tasmanian tiger back into transgenic mice to see how it would function, according to a paper published in PLoS ONE. Finding that thylacine Col2A1 enhancer directed chondrocyte-specific expression in the tiger the same way it does in mice, this is the first time that DNA from an extinct species has been used to examine function in a living organism.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.